and signs associated with these infections so she can present for care at the earliest possible time.
Infect. Dis When symptomatic cuff cellulitis develops, the non-penicillin allergic patient often can be treated with an oral broad spectrum regimen such as amoxicillin with sodium clavulanate (Augmcntin (R) 250-500 nag every 8 h. Clindamycin 450 mg orally every 6 h is an alternative for the penicillin allergic patient. For most women with pelvic infections other than cuff cellulitis, parcnteral antibiotic therapy is necessary, and women usually promptly respond to parenteral antimicrobial therapy. Parenteral antibiotics should not be administered to women given the diagnosis of presumed pelvic infection without a pelvic examination. Cefotaxime (Claforan(R)) g q 8 h Cefotetan (Cefotan(R)) 2 g q 12 h
Cefoxitin (Mefoxin(R)) 2 g q 6 h Imipenem/cilastatin (Primaxin(R)) 500 mg q 8 h Meropenem (Merem(R)) 500 mg q 8 h Piperacillin (Piperacil(R)) 4 g q 6 h Piperacillin and tazobactam (Zosyn(R)) 3 .375 g q 6 h therapy is continued until the patient has been afebrile 24-36 h. Oral antibiotic therapy is unnecessary after successful parenteral therapy. 6 The most important consideration in antibiotic selection is predictable efficacy. Infections are polymicrobial, and a broad spectrum of antibacterial activity is necessary. The regimens listed in Table 3 During treatment for infection, the patient should be monitored at least twice daily to insure success and to detect any adverse reaction which might develop. Almost all superficial incisional infections respond to opening and draining the area with local wound care 3 times daily consisting of irrigation and debriding with solutions such as hydrogen peroxide or acetic acid followed by normal saline. Fine mesh gauze applied directly to the incisional margins and medial packing with 4 x 4s, or other sterile packing speeds granulation tissue development. Antibiotic therapy is not usually necessary. These wounds may be closed or allowed to heal by secondary intention.
Antibiotic treatment failures are uncommon.
They may result from 1) development of resistant species; 2) superinfection by different species in the infection site; 3) lack of coverage for the pathogen by the empiric regimen; or 4) volume of infection. Adding to or changing the empiric antibiotic regimen to expand predictable coverage will be successful. In patients with an infected hematoma or abscess, draining will usually facilitate cure. The patient also may have a non-operative site infection, and drug fever must be remembered.
